Adial Pharmaceuticals ADIL
NASDAQ ADIL
$4.01 -0.14 (-3.37%)
At close: Sep 30, 2026 · 4:00 PM EDT

Adial Pharmaceuticals (ADIL) Accounts Payables (2017 - 2026)

Updated

Adial Pharmaceuticals (ADIL) posted Accounts Payables of $2.62 million for Q2 2026, up 291.0% from $671,118 a year earlier and up 357.5% from the prior quarter.

Analysis

Adial Pharmaceuticals (ADIL) Accounts Payables (2017 - 2026) Analysis & Trends

At the end of FY2025, Adial Pharmaceuticals' Accounts Payables came in at $655,000, up 161.9% from FY2024.

  • Annual Accounts Payables shows a five-year compound annual growth rate of 0.2% (FY2020 to FY2025).
  • In prior years, Adial Pharmaceuticals' Accounts Payables was $250,130 in FY2024 (+142.1%), $103,325 in FY2023 (-62.6%), $276,410 in FY2022 (-3.4%) and $286,192 in FY2021 (-55.9%).
  • The Q2 2026 figure stands as the highest quarterly Accounts Payables in data going back to Q4 2017.
  • On a year-over-year basis, Accounts Payables has increased in each of the last nine quarters, with growth averaging 159.7% over the last eight quarters.
  • The strongest year-over-year quarter for Accounts Payables in the past five years was Q2 2026, with growth of 291.0%; the weakest was Q2 2023, with a decline of 81.9%.
  • According to Business Quant data, Accounts Payables for the three prior quarters was $573,567 (Q1 2026), $655,000 (Q4 2025) and $556,284 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 9.22 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 33.30 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -22.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 674.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 429.50 Mn
10 Adial Pharmaceuticals 18.53 Mn 18.53 Mn - 2.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.62 Mn
Mar 31, 2026 573,567.00
Dec 31, 2025 655,000.00
Sep 30, 2025 556,284.00
Jun 30, 2025 671,118.00
Mar 31, 2025 532,430.00
Dec 31, 2024 250,130.00
Sep 30, 2024 318,118.00
Jun 30, 2024 316,726.00
Mar 31, 2024 177,468.00
Dec 31, 2023 103,325.00
Sep 30, 2023 81,925.00
Jun 30, 2023 111,702.00
Mar 31, 2023 530,141.00
Dec 31, 2022 276,410.00
Sep 30, 2022 278,200.00
Jun 30, 2022 617,778.00
Mar 31, 2022 415,086.00
Dec 31, 2021 286,192.00
Sep 30, 2021 185,187.00
API Access

Adial Pharmaceuticals Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=ADIL&period=max&api_key=YOUR_API_KEY